TCL Archive Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market August 2, 2002
TCL Archive The New NCI: Structure, Procedures, Advisory Boards To Change, Klausner Says September 15, 1995
TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive Institutinal Training Awards Hardest Hit As New Budget Cuts Will Slash Into Noncompeting Grants March 13, 1981